ArticleLiver cancer2023

Prioritized Requirements for First-Line Systemic Therapy for Hepatocellular Carcinoma: Broad Benefit with Less Toxicity.

Masatoshi KudoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.